Abstract: The invention relates to a manufacturing method for a crash frame of a battery compartment for electric drive vehicles by using metallic sheets which are arranged on top of one another and fixed together and which form in a following step a space by using an inner active media forming process to create walls of a crash frame whereby the space works as a deformation space to protect the battery modules inside the battery compartment against an impact. The invention further relates to the use of the crash frame for a battery compartment.

Abstract: An absorbent article (20, 20?) comprising a topsheet (58), a backsheet (42,60), and an absorbent core (62), and at least one nonwoven-nonwoven adhesive bond other than a core stabilization bond, wherein the adhesive of the adhesive bond has a Toughness of at least 11 MJ/m3, a Yield Stress of at least 0.7 MPa. The adhesive may further have a storage modulus G? of at least 7.5 MPa. These are as measured at 37° C. according to the methods described herein. The adhesive comprises at least 5% by weight of the adhesive of a tackifier.

Abstract: A roof module for a motor vehicle may have a roof skin, a roof frame on a vehicle body and have at least one transverse frame part extending in the transverse roof direction and a longitudinal frame part extending in the longitudinal roof direction on either side of a longitudinal center roof plane, and a roof opening system having a lid element configured to be displaced on guide rails, which are part of the longitudinal frame parts of the roof frame, in the longitudinal roof direction relative to the roof frame, and/or a solid roof element having a transparent see-through portion and being rigidly connected to the roof frame, having a sensor system comprising at least one sensor module which has at least one environmental sensor and is located outside of the roof opening and/or outside of the transparent see-through portions and is covered by a cover element.

Abstract: The invention relates to an illuminant device for emitting light of a continuously adjustable colour, more particularly for individualizing and/or illuminating an interior, comprising the following: at least one illuminant unit comprising a plurality of illuminant elements; at least one driver unit which is configured to output driver current signals to the illuminant elements of the illuminant unit in such a way that a target colour of the illuminant unit can be set in accordance with the driver current signals; at least one computing unit, which is configured to calculate the driver current signals necessary for setting the target colour and to control the driver unit accordingly so that the driver unit outputs the driver current signals.

Abstract: The present invention relates to a compound of formula (I), a pharmaceutical composition comprising or consisting of said compound, a kit comprising or consisting of said compound or pharmaceutical composition and use of the compound or pharmaceutical composition in the diagnosis or treatment of a disease characterized by overexpression of fibroblast activation protein (FAP).

Abstract: A roof module for a motor vehicle, in particular for a passenger car, the roof module comprising a roof skin disposed on a roof substructure and a sensor system comprising at least one sensor module having at least one environment sensor for detecting the vehicle environment. The roof skin covers an air-conditioning mechanism having a thermal channel arrangement via which a cooling and/or heating fluid flows to the sensor module and/or an electrical feature of the roof module.

Abstract: In particular, the present invention relates to a PSMA binding ligand comprising an oligosaccharide building block which comprises a bond being cleavable by alpha-amylase. Typically, this PSMA binding ligand further comprises a PSMA binding motif Q and a chelator residue A, wherein the PSMA binding motif Q and the chelator residue A are preferably linked via at least one linker LAQ comprising the oligosaccharide building block, the PSMA binding ligand thus preferably having the structure (I) A-LAQ-Q or a pharmaceutically acceptable salt or solvate thereof.

Abstract: A roof module for connection to a motor vehicle having a transparent solid roof portion, which forms a see-through roof area and which is immobile relative to the vehicle body when the roof module is in the installed position, and/or a roof opening system having a mobile lid element, by means of which a roof opening can be opened or closed at will, and a closed roof skin, which forms the see-through roof area and/or is adjacent to the roof opening and forms a roof cover outside of the see-through roof area and/or the roof opening. At least one sensor module can be provided having at least one environment sensor for detecting a vehicle environment and is disposed outside of the see-through roof area and/or the roof opening and is covered by the roof skin.

Abstract: A roof module for forming at least a part of the vehicle roof on a motor vehicle, the roof module having a panel component whose outer surface at least partially forms the roof skin of the vehicle roof, the roof module having at least one environment sensor configured to send and/or receive electromagnetic signals for detecting the vehicle surroundings. The roof module has at least one antenna module configured to receive and/or send radio signals.

Abstract: A roof module of a motor vehicle having a roof substructure, a roof cladding, which forms an outer visible surface of the roof module, and at least one sensor module having an environment sensor for sensing a vehicle environment, the roof cladding having a central section having a curved surface and at least one edge section, which adjoins the central section and whose incline is larger than the incline of the central section and which is transparent to the environment sensor at least in the area of a signal cone of the environment sensor. The environment sensor being at least partially disposed below a roof surface defined by the roof cladding.

Abstract: The invention provides for a medical imaging system (100, 300) comprising a processor (106) for controlling the medical imaging system. Execution of machine executable instructions (112) causes the processor to receive (200) a static angiographic image (114) of a region of interest (322), receive (202) a time series of angiographic images (116, 116?) of the region of interest, construct (204) an image mask (118) using the static angiographic image, determine (206) a time dependent signal (120) for each voxel within the image mask using the time series of angiographic images, construct (208) a composite angiographic image by: assigning (210) a fill time (126) to each voxel within the image mask using an extremum (124) of the time dependent signal if the extremum deviates from an average of the time dependent signal more than a predetermined threshold, and identifying (212) voxels within the image mask as being unfilled voxels.

Abstract: A roof module for a motor vehicle may have a roof skin, a roof frame on a vehicle body and have at least one transverse frame part extending in the transverse roof direction and a longitudinal frame part extending in the longitudinal roof direction on either side of a longitudinal center roof plane, and a roof opening system having a lid element configured to be displaced on guide rails, which are part of the longitudinal frame parts of the roof frame, in the longitudinal roof direction relative to the roof frame, and/or a solid roof element having a transparent see-through portion and being rigidly connected to the roof frame, having a sensor system comprising at least one sensor module which has at least one environmental sensor and is located outside of the roof opening and/or outside of the transparent see-through portions and is covered by a cover element.

Abstract: A wafer suitable for epitaxial growth of gallium nitride (GaN) in a Metal Oxide Chemical Vapor Deposition (MOCVD) process. The wafer includes a silicon substrate having a front side and a back side and an edge extending between the front side and the back side, the edge including a front bevel surface connected to the front side and a back bevel surface connected to the back side, wherein the silicon substrate comprises an oxygen denuded silicon layer surrounding a core. The wafer further includes a protection layer being a thermally grown silicon oxide (SiO2) layer substantially covering the front bevel surface and the back bevel surface of the edge, while leaving at least a central region of the front side of the silicon substrate exposed, for preventing meltback during the MOCVD process.

Abstract: A method of treating cut stem tobacco material by expanding the cut stem to provide a first expanded tobacco material having a fill value at least about 10% greater than the fill value of the untreated cut stem tobacco material; intermittently contacting the first expanded tobacco material with a heated surface to provide a second expanded tobacco material with a moisture content of from 0 to about 10% OV and a fill value at least 5% greater than the fill value of the first expanded tobacco material; and (c) adjusting the moisture content of the second expanded tobacco material from about 5% to about 30% OV to provide an expanded product, wherein the fill value of the expanded product is at least 50% greater than the fill value of the untreated cut stem tobacco material when measured at a normalized moisture content of 14.5% OV.

Abstract: A magnetic resonance imaging system (100) for acquiring magnetic resonance data (141) from an imaging zone (108) includes a memory (134, 136) for storing machine executable instructions (150, 152, 154, 156) and pulse sequence commands (140). The pulse sequence commands cause the magnetic resonance imaging system to provide at least one spatially selective saturation pulse (408, 410) to at least one selected volume (124, 124?) that is at least partially outside of a region of interest (123) and within the imaging zone. The magnetic resonance imaging system performs a non-selective inversion (412) of spins in the region of interest followed by a readout (414) of the magnetic resonance data which is reconstructed (202) into an image (142).

Abstract: The present invention relates to a compound of formula (I), a pharmaceutical composition comprising or consisting of said compound, a kit comprising or consisting of said compound or pharmaceutical composition and use of the compound or pharmaceutical composition in the diagnosis or treatment of a disease characterized by overexpression of fibroblast activation protein (FAP).

Abstract: The invention provides for a medical imaging system (100, 300) comprising a processor (106) for controlling the medical imaging system. Execution of machine executable instructions (112) causes the processor to receive (200) a static angiographic image (114) of a region of interest (322), receive (202) a time series of angiographic images (116, 116?) of the region of interest, construct (204) an image mask (118) using the static angiographic image, determine (206) a time dependent signal (120) for each voxel within the image mask using the time series of angiographic images, construct (208) a composite angiographic image by: assigning (210) a fill time (126) to each voxel within the image mask using an extremum (124) of the time dependent signal if the extremum deviates from an average of the time dependent signal more than a predetermined threshold, and identifying (212) voxels within the image mask as being unfilled voxels.

Abstract: The present invention relates to compounds, pharmaceutical compositions and methods for treating different forms of cancer and angiogenesis related diseases using cyclic peptides.

Abstract: The present invention relates to compounds, pharmaceutical compositions and methods for treating different forms of cancer and angiogenesis related diseases using cyclic peptides.

Abstract: A method of magnetic resonance imaging (100, 200) includes acquiring (300) tagged magnetic resonance data (144) by controlling the magnetic resonance imaging system with tagging pulse sequence commands (140). The tagging pulse sequence commands include a tagging inversion pulse portion (404) for spin labeling a tagging location (122, 122?) within a subject (118). The tagging pulse sequence commands comprise a phase-contrast readout portion (406) which phase-contrast encodes in at least one direction. The control pulse sequence commands include a control inversion pulse portion (500) and the phase-contrast readout portion. A tagged magnitude image (148) is reconstructed (304) using the tagged magnetic resonance data. A control magnitude image (150) is reconstructed (306) using the control magnetic resonance data. An arterial image (152) is reconstructed (308) by subtracting the control magnitude image and the tagged magnitude image.